Radiology Positioning Aids Market Size Worth $359.1 Million By 2026

The global radiology positioning aids market size is expected to reach USD 359.1 million by 2026, according to a new report by Grand View Research, Inc., registering a 5.7% CAGR during the forecast period. Increasing cases of bone fractures, along with growing prevalence of cancer, tumors, and other digestive conditions, is expected to drive the overall market.

North America was identified as the dominant region in 2018 in terms of market share and is expected to grow at a significant pace throughout the forecast period. The increasing momentum observed in this region is largely attributed to growing geriatric population, who are prone to fractures, and increasing product demand in hospitals.

Frequent introduction of innovative positioning aids are expected to impact the market dynamics during the forecast period. Introduction of advanced imaging systems boosts demand for newer types of positioning aids. Increasing number of standalone radiology centers in developing countries is expected to fuel the market.

Growing partnerships among players and suppliers to increase the reach of these products is expected to result in increased penetration and availability of these products. Moreover, courses for radiology and positioning is also expected to drive the radiology positioning aids market during forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/radiology-positioning-aids-market

Further key findings from the report suggest:

The wedge X-ray segment is predicted to register significant growth over the forecast period owing its advance angled design that helps in providing proper image along with enhanced patient comfort
Head, neck, and brain related devices are anticipated to hold maximum share in the forthcoming years due to growing number of cases associated with these anatomy
Hospitals is anticipated to hold a larger share in radiology positioning aids market owing to growing adoption of different advanced X-ray or radiology devices such as X-ray devices with different material such as polyurethrane
Asia Pacific is anticipated to witness considerable growth over the forecast period due to improving healthcare facilities and adoption of advanced imaging devices for proper diagnosis
Major market players include Bionix Radiation Therapy; CIVCO Radiotherapy; AADCO Medical, Inc.; IZI Medical Products; Varian Medical Systems, Inc.; Elekta AB; VERTEC LTD.; and Klarity Medical Products. These players are focusing on expanding their distribution network by forming associations with suppliers.

Clip Applicator Market Size Worth $8.0 Billion By 2026

The global clip applicator market size is expected to reach USD 8.0 billion by 2026 according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 7.0% during the forecast period. Rise in laparoscopic surgeries and high demand for minimally invasive procedures are projected to propel the growth.

The number of laparoscopic surgeries is increasing annually. As per the data published by June Medical, around 1.5 million laparoscopic surgeries are performed in U.K. every year. Growth in the number of laparoscopic surgeries is attributed to increasing acceptance and popularity among both doctors and patients. This factor is anticipated to augment the demand for clip applicator over the forecast period.

Rising prevalence of gastrointestinal diseases and cancers among other diseases that require endoscopy procedures, is one of the factors boosting the market growth. In addition, prevalence of chronic diseases among baby boomers, awareness regarding novel devices as well as rising preference for minimally invasive surgeries is anticipated to support the market growth. Recent endoscopy techniques have revolutionized the examination and treatment of upper gastrointestinal tract including duodenum, stomach, and esophagus, and the colon.

Growing number of gynecology surgeries is also driving the clip applicator market. As per a study by the Japan Society of Obstetrics and Gynecology, the number of endoscopic surgeries increased from 56, 233 surgeries in 2014 to 80, 678 in 2016 nationwide.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/clip-applicator-market

Further key findings from the report suggest:

Endoscopic appliers segment registered the highest market share in 2018 owing to availability of single and multi-firing clip device required for proper closure of incisions in Peroral Endoscopic Myotomy (POEM)
Laparoscopic appliers segment is anticipated to expand at the fastest CAGR over the forecast period owing to innovations in devices in terms of significant cost savings in laparoscopic procedure
North America accounted for a significant clip applicator market share in 2018, attributed to the increase in geriatric population, number of surgeries, high adoption rate of technologically advanced devices, and high awareness regarding the benefits of minimally invasive surgeries
Asia Pacific is anticipated to expand at the fastest CAGR over the forecast period supported by improving healthcare infrastructure and growing medical tourism due to affordability
Some of the players operating in the market includes B. Braun Melsungen, LUMED, Unimax Medical Systems, Betatech, Geyi Medical, Mediflex, Medscope, CONMED Corporation, Medtronic, J&J Medical Devices, Millennium Surgical Corp, and Teleflex Incorporated

Sacral Nerve Stimulation Market Size Worth $2.39 Billion By 2026

The global sacral nerve stimulation market size is anticipated to reach USD 2.39 billion by 2026 registering a CAGR of 13.7%, according to a new report by Grand View Research, Inc. Increasing incidence of urge incontinence and fecal incontinence is anticipated to boost the market growth. Several other factors that are expected to drive the market include increase in number of patients suffering from urge incontinence, urgency frequency and urinary retention. According to the Department of Obstetrics and Gynecology, India, urge incontinence affects 23.0 to 55.0% of women.

Increasing number of patients suffering from Urinary Tract Infection (UTI) is also contributing toward the market growth. UTI is very common in females. Technological advancements are also likely to boost market growth. For instance, Medtronic InterStim II neurostimulation system. This system electrically stimulates the sacral nerves to normalize neural communication between the bladder and the brain, and between the bowel and the brain. It is designed for the treatment of urinary retention, Overactive Bladder (OAB) including urinary urge incontinence and symptoms, such as urgency frequency in patients who had failed to tolerate more conservative treatments.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/sacral-nerve-stimulation-sns-market

Further key findings from the study suggest:

Implantable devices led the global sacral nerve stimulation (SNS) market in 2018 due to increased number of patients suffering from OAB and urinary incontinence
Urine and fecal incontinence application segment is expected to witness the fastest CAGR from 2018 to 2026 owing to increasing cases of urine and fecal incontinence
North America led the SNS market in 2018 and will maintain its dominance throughout the forecast years owing to the rising cases of urge incontinence, OAB, and UTI and increasing investments in the development of innovative SNS systems
Some of the key companies in the global sacral nerve stimulation market are Medtronic PLC; Axonics Modulation Technologies, Inc.; Nuvectra; and Cogentix Medical

3D Printed Surgical Models Market Size Worth $1.1 Billion By 2026

The global 3D printed surgical models market size is expected to reach USD 1.1 billion by 2026, expanding at a CAGR of 10.3%, according to a new report by Grand View Research, Inc. Improving diagnosis as well as the context of the patient’s pathology is driving the market. Increasing use of advanced healthcare technologies for better understanding of patients and minimization of risk during the actual surgical procedure is boosting the demand for 3D printed surgical models.

The introduction of synthetic modeling of human anatomy has made a significant leap forward. The 3D printed surgical models allow preadoption of surgical instruments by improving the 3D perception of the planned operation. The technology also enables surgeons to envision, practice, and then perform the actual surgery for saving time and increasing precision. These models can also be used to perform mock surgeries, thereby improving the prediction of the outcomes.

Advanced medical models are anatomically accurate, highly functional, and biomechanically realistic and are liberated from the cost and inconvenience to the animal as well as cadaver labs. They are perfect for simulating clinical procedures such as suturing, cutting, reaming, drilling, and even device placement. Some of the most advanced three-dimensional structures can even mimic bleeding, coming as close as possible to reality, which would enhance the efficiency and accuracy of surgical procedures.

The 3D printed anatomical models can help in numerous aspects, including educating young surgeons about tactile and three-dimensional inspection of the tissues. They are also used to help patients prepare for surgery.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/3d-printed-surgical-models-market

Further key findings from the study suggest:

The orthopedic surgery segment accounted for highest revenue in 2018 as the 3D models can assist in pre-operative planning by defining the geometry of bone loss, tumor mass, and nearby vessels to determine the most appropriate osteotomy site along with most appropriate prosthesis
The neurosurgery segment is anticipated to witness the fastest CAGR of 11.3% over the forecast period. This is due to increase in the use of 3D models to describe complex anatomical structures to patients
North America held the largest share accounting for 35.3% of the global market share in 2018. This is attributed to the U.S. offering the most sophisticated healthcare infrastructure comprising multispecialty hospitals and clinics, thereby increasing the demand
Some of the players operating in the market are Stratasys, Ltd.; 3D Systems, Inc.; Lazarus 3D, LLC; Osteo3d; Axial3D; Onkos Surgical; Formlabs, Materialise NV; 3D LifePrints UK Ltd.; and WhiteClouds.

Smart Insulin Pens & Pumps Market Size Worth $6.3 Billion By 2026

The global smart insulin pens and pumps market size is expected to reach USD 6.3 billion by 2026, registering around 10.0% CAGR over the forecast period according to a new report by Grand View Research, Inc. Major market drivers include continuous technological advancements in the field of diabetes care along with growing adoption of advanced diabetes management methods. The rising geriatric population coupled with the increasing incidence of diabetes as lifestyle associated disease are the factors expected to drive the product demand. Self-injection devices with integrated connectivity have become an important element of the digital ecosystem.

Smart insulin pens and pumps have created new standards for diabetes care. With the advent of Artificial Intelligence (AI), the entire paradigm of diabetes management has been transformed from simple Bluetooth enabled insulin delivery devices to an artificial pancreas. Furthermore, increasing investment and rising number of new product launches are expected to widen growth opportunities. For Instance, in July 2017, Cellnovo a French medtech company announced to raise USD 19.27 million to improve its product and to continue the R&D in artificial pancreas system. Many key players are focusing on technological collaborations, which is expected to have a long-term positive impact on the market. For instance, in September 2019, Medtronic collaborated with Novo Nordisk to integrate Novo future smart insulin pen dosage data with Medtronic CGM devices.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/smart-insulin-pens-pumps-market

Further key findings from the study suggest:

North America dominated the market in 2018 owing to favorable reimbursement policies, presence of key players, and high adoption rates for advanced technologies
By insulin pump types, Medtronic’s MiniMed accounted for the largest market share in 2018 and is expected maintain its dominance over the forecast period
Companion medical Inpen is expected to register the fastest CAGR over the forecast period, owing to high adoption rate and advanced features
By end use, hospital segment held the largest share of the smart insulin pens and pumps market in 2018. Homecare segment, on the other hand, is expected to register the fastest CAGR during the forecast period
The leading players present in the market are Companion Medical Inc.; Novo Nordisk; Emperra Gmbh E-Health technologies; Jiangasu Delfu medical device Co Ltd; Insulet Corporation;Cellenovo; Medronic Inc.; F Hoffmann-La Roche; Ypsomed; Tandem Diabetes Care; Sooil Development; Valeritas Inc.; and others. Major players are focusing on technological collaboration and product launches

Urology Lasers Market Size Worth $1.4 Billion By 2026

The global urology laser market size is anticipated to reach USD 1.4 billion by 2026, according to a new report by Grand View Research, Inc., registering a CAGR of 5.7% over the forecast period. registering a CAGR of 5.7% over the forecast period. The increasing demand for minimally invasive surgeries, rise in the number of patients suffering from urinary calculi, and technological advancements in urology lasers is anticipated to boost the market growth.

The demand for lasers in urology is rising due to the increasing preference for minimally invasive surgeries as these procedures reduce morbidity, dysfunction, and have the ability to ablate prostate tissue with minimal hemorrhage or bleeding. They also offer advantages such as quicker recovery from surgery, lower risk of bleeding, and enable a shorter bladder catheterization time, sometimes even eliminating the need for bladder catheterization completely. These procedures are also characterized by more stable outcomes and lower number of reoperations. Lasers are used for the treatment of various urological disorders such as Benign Prostatic Hyperplasia (BPH) and urolithiasis. According to the American Urological Association, around 8.8% of the U.S. population are affected by urinary stones. Thus, increasing prevalence of urological disorders such as urolithiasis, nephrolithiasis, and BPH are also contributing toward market growth.

With equipment advancement, better understanding of urologists’ needs on the part of producers, and growing experience of operators, these treatments are a favorable alternative to traditional surgical procedures. Technological advancements in urology lasers have expanded the portfolio for the types used in various surgeries, including urologic operations. For instance, holmium (Ho:YAG) lithotripters were traditionally used with two parameters, pulse frequency and pulse energy, to define the duration of lithotripsy. With technological advancements, high-powered high-frequency long-pulse Ho:YAG lithotripters are now available. These enable ultra-high pulse frequencies (up to 80 Hz), further speeding up the dusting lithotripsy procedure.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/urology-laser-market

Further key findings from the study suggest:

The Benign Prostatic Hyperplasia (BPH) segment dominated the market in 2018 owing to the increasing prevalence of BPH in men and rise in demand for minimally invasive surgeries
The thulium system segment is expected to register the highest CAGR during the forecast period as it is a safe and highly effective system in terms of tissue resection speed and preventing blood loss
North America dominated the overall market with the highest revenue share in 2018 owing to the increasing prevalence of urological disorders such as urolithiasis and BPH coupled with growing awareness of this treatment in the region
Key players in the urology lasers market are introducing innovative and technologically enhanced products to gain competitive advantage in the industry. For instance, in 2017, Lumenis launched Moses Holmium Technology to reduce retropulsion during lithotripsy procedure. It is designed to minimize ureteric as well as bladder stone migration. It reduces stone retropulsion and, in turn, stone migration, leading to a more efficient treatment and greater physician control over the procedure.

Intraoperative Imaging Market Worth $4.44 Billion By 2026

The global intraoperative imaging market size is anticipated to reach USD 4.44 Billion by 2026, registering a 5.9% CAGR during the forecast period, according to a new report by Grand View Research, Inc. Rising demand for minimal invasive surgical solutions and increasing application of intraoperative imaging technology in neuro and orthopedic surgeries is expected to contribute towards the growth of the market.

Improving quality of healthcare services especially in the developing countries and stringent guidelines towards patient safety is leading to boost the adoption of advance intraoperative technology. Moreover, adoption of intraoperative devices has helped healthcare facilities in saving costs on repeat operation, thus significantly decreasing overall financial burden on patients

Increasing incidence of neurological disorders such as Parkinson’s, stroke, epilepsy, Alzheimer’s, and dementia is expected to drive the demand for advanced brain surgery solutions including intraoperative imaging. Furthermore, rapidly growing number of spinal fusion and other orthopedic surgeries such as knee and hip replacements and growing trends of minimally invasive procedures installing implants is expected to fuel the market.

Technological advancement in intraoperative Imaging systems is an emerging trend witnessed in the market. These developments include 3D, 4D imaging technology coupled with an efficient guiding and dose management systems which doesn’t affect the surgical procedure time. Such growing development in Intraoperative imaging devices is expected to drive the market during the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/intraoperative-imaging-market

Further key findings from the report suggest:

Based on the product, iCT holds the largest market share and is also expected to grow at a significant rate over the forecast period. Wider application of iCT across several surgical procedures coupled with introduction of innovative technology such as C-arm CT system, low dose exposure systems, pediatric intraoperative CT systems, is expected to propel intraoperative imaging market growth.
Based on Application, neurosurgery and orthopedic surgery market are leading the market. The driving factors are the growing prevalence of neurological disorders across the globe and increasing number of surgeries such as spinal fusion, knee replacement.
Hospital held the largest market share in 2018. Larger patient pool, rising adoption to minimal invasive surgeries, availability of specialist surgeons, and advance technology is expected to propel the growth of this segment.
North America held the largest market share in 2018. Presence of major market players and developed healthcare infrastructure is expected to contribute towards the growth of market in this region.
Asia Pacific is expected to grow at the fastest rate over the forecast period due to rapidly developing economy and healthcare services especially in the countries like India and Indonesia. The increasing popularity of intraoperative imaging technology coupled with large unmet needs in the regions of Asia Pacific is expected to drive the growth of this market.

Hearing Aids Market Size Worth $7.3 Billion By 2025

The global hearing aids market size is expected to reach USD 7.3 billion by 2025, expanding at a CAGR of 4.6% over the forecast period, according to a report by Grand View Research, Inc. Increasing adoption of hearing aids, growing awareness about technologically advanced products for treatment of auditory loss, and rising prevalence of auditory loss are some of the factors contributing to the market growth over the forecast period.

Behind-the-ear hearing aids was the largest product type segment in 2018 and is expected to grow at a lucrative rate over the forecast period. This is because they are easy to handle and clean and are more preferred by younger population. Moreover, they can fit into various ear molds and don’t need device replacement as the child grows. With technological advances, new products such as the Mini BTE have been developed, which are smaller in size and provide more comfort.

The digital technology dominated the market in 2018 and is expected to retain its position over the forecast period. Digital technology hearing aids are technologically advanced and can be programmed according to the external environment to amplify sound and reduce noise, thus providing an enhanced auditory experience.

The retail sales channel segment dominated the market in 2018 and is expected to grow at a lucrative rate over the forecast period. This can be attributed to higher profit margin in retail stores and increasing number of companies investing in company-owned retail stores to gain higher revenue share. In addition, companies such as William Demant Holding A/S, Starkey, and GN Hearing are undertaking expansion strategies to increase the number of company-owned retail stores.

Europe dominated the market in 2018 with a revenue of USD 2.2 billion and is expected to grow at a lucrative rate over the forecast period. This is owing to increase in prevalence of auditory loss, growing awareness about various treatment options, and rising adoption of hearing aids. Asia Pacific is anticipated to exhibit the fastest growth, due to large population base, coupled with increasing geriatric population, easy availability and accessibility of hearing aids.

Some of the key market players in the market are Phonak; Benson Hearing; GN Store Nord A/S; Starkey; MED-EL.; William Demant Holding A/S; Medtronic; WIDEX USA, INC.; and Sivantos Pte. Ltd. These companies focus on technological innovations, new product launches, and regional expansion to gain a competitive edge.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/hearing-aids-market

Further key findings from the study suggest:

Behind-the-ear hearing aids was the largest product segment and is expected to grow at a lucrative rate over the forecast period due to ease of handling and technological advances
The digital technology dominated the market in 2018 owing to technological advancements and additional advantages over its analog counterparts, including amplified sound and reduced external noise
Retail sales channel dominated the hearing aids market in 2018 with a revenue of USD 3.9 billion due to high profit margins in retail sales and increasing number of companies investing in company-owned retail stores
Asia Pacific is anticipated to witness the fastest growth with a CAGR of 7.3% owing to high population base, coupled with increasing geriatric population, and easy availability and accessibility of hearing aids
Some of the key players are Phonak; Benson Hearing; GN Store Nord A/S; Starkey; MED-EL.; William Demant Holding A/S; Medtronic; WIDEX USA, INC.; and Sivantos Pte. Ltd.

Acute Hospital Care Market Worth $4.0 Trillion By 2026

The global acute hospital care market is expected to reach USD 4.0 trillion by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 6.7% over the forecast period. Market growth can be attributed to a significant increase in number of patients suffering from chronic diseases such as cancer, diabetes, heart disease, and stroke. Increase in incidence of trauma, demand for acute hospitals; patient volume, including, geriatric demographic; and unmet medical needs is expected to boost growth. In addition, technological advancements for improving quality of treatment to reduce Length of Stay (LOS) and achieve a faster Turnaround Time (TOT) are expected to aid growth.

Rise in demand for such hospitals is likely to create opportunities for players. Large hospitals are further addressing the increase in demand by building more facilities. These include HCA Healthcare, Inc.; Tenet Healthcare Corporation; & Community Health Systems, Inc. in the U.S. and Fresenius Medical Care & Ramsay Healthcare in Europe.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/acute-hospital-care-market

Further key findings from the report suggest:

Based on medical conditions, emergency care dominated the market in 2018, due to increase in number of patients at hospitals seeking admission for shorter durations. This includes cases of trauma, injury, respiratory disorders, or cardiac problems such as acute myocardial infarction.
Furthermore, availability of higher reimbursement for treatment, when compared with other facilities, supports segment growth
Based on facilities, general acute care facilities held the largest share in 2018, due to majority of admission cases requiring short-term emergency medical attention.
Patients suffering from acute illnesses, diseases, or injuries are first admitted to these facilities
Psychiatric hospitals offering acute psychiatric treatment to patients are expected to grow at the fastest rate over the forecast period. This can be attributed to the increase in prevalence of stroke due to risk factors such as increase in smoking & alcohol consumption and poor lifestyle choices
ICUs dominated the service segment in 2018, owing to increase in number of patients seeking intensive monitoring and round-the-clock nursing.
Hospitals are investing in specialized ICUs for specific issues pertaining to cardiology and surgical & medical needs. NICU is expected to be one of the fastest growing segments over the forecast period
The acute hospital care market has recently experienced expansion of facilities through mergers & acquisitions by key players, which, combined various services, increased overall market revenue
Some key players are Tenet Healthcare Corporation; Fresenius Medical Care; Ramsay Healthcare; Asklepios Kliniken GmbH; Universal Health Services, Inc.; HCA Healthcare, Inc.; Community Health Systems, Inc.; Ascension Health; IHH Healthcare; Mediclinic International; Legacy Lifepoint Health, Inc.; and Ardent Health Services

Empty IV Bags Market Size Worth $5.6 Billion By 2026

The empty IV bags market size is expected to reach USD 5.6 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 8.1%. Rising incidence of cancer, favorable government initiatives related to non-PVC IV bags, and growing risk of malnutrition across the globe are the key driving factors for the market.

Government agencies of various countries are taking several steps to reduce usage of phthalate IV bags wherever possible without compromising on patient safety. For instance, Denmark introduced a national ban on Di-(2-ethylhexyl) phthalate (DEHP), Dibutyl Phthalate (DBP), Dibp Plasticizer (DIBP), and Butyl Benzyl Phthalate (BBP) under its national phthalate strategy, which was initially set for December 2013 and was later postponed to 2015. The Danish Health and Medicines Authority (DHMA) announced certain set of guidelines pertaining to usage of particular types of phthalates in medical devices. The aim of these initiatives was to ensure continued reduction in the use of classified phthalates in medical devices. Similarly, in May 2006, the Federal Institute for Drugs and Medical Devices, Germany, issued a recommendation for hospitals to minimize or avoid use of DEHP-containing medical devices for specific population groups, such as premature babies, infants, children, adolescents, pregnant women, and nursing mothers. The recommendation necessitates manufacturers to produce alternative products that are PVC-free and nontoxic.

Malnutrition is one of the major drivers of the market. According to the UNICEF, poor nutrition in the first 1,000 days of an infant’s life may lead to stunted growth and impaired cognitive ability. An infant’s diet must contain a proper balance of starch, minerals, vitamins, amino acids, and lipids. These essential nutrients can be administered, if need be, through parenteral route, which is expected aid growth.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/empty-iv-bags-market

Further key findings from the report suggest:

In terms of revenue, non-PVC empty IV bags segment held the largest share in 2018 owing to the environment-friendliness of non-PVC
The demand for multi-chambered bags is expected to increase due to presence of separate storage for different components
Under the type segment, single chambered empty IV bags held the largest share in 2018
Asia Pacific is expected to witness the fastest growth over the forecast period, owing to growing malnutrition in the region
Some prominent players in empty IV bags market are Technoflex, Wipak Group, Baxter, and ICU Medical, Inc.